
To assess the European Association of Urology (EAU) risk groups for biochemically recurrent (BCR) prostate cancer relative to PSMA‐PET status and oncological outcomes. A retrospective analysis of a study incorporating PSMA PET for men with BCR after radical prostatectomy (RP) was undertaken. EAU risk groups were considered relative to clinical variables, PSMA PET findings, and deployment of salvage radiation treatment (SRT). The primary oncological outcome was event‐free survival (EFS) and analysed relative to clinical and imaging variables. 137 patients were included, with the most high EAU risk (76%) and/or low PSA (80% <0.5ng/ml) at the time of PSMA PET. EAU risk was not associated with PSMA PET regional nodal/distant metastases. In men with post‐RP BCR, PSMA‐PET findings and receipt of SRT predicted EFS. In addition, in men receiving SRT, PSMA status combined with EAU risk grouping was most predictive of EFS.
Like
Save
Share